Data Bank for Eosinophilic Disorders
Launched by MARC ROTHENBERG · Dec 19, 2005
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Patients with an eosinophil associated gastrointestinal disorder (EGID), family members of patients with EGID, or normal controls.
About Marc Rothenberg
Marc Rothenberg is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With extensive experience in the pharmaceutical and biotechnology sectors, Rothenberg specializes in designing and overseeing innovative clinical trials that adhere to the highest ethical and regulatory standards. His focus on collaboration with research institutions and healthcare professionals ensures that trials are conducted efficiently and effectively, fostering the development of groundbreaking therapies. Through a patient-centered approach and a dedication to scientific excellence, Marc Rothenberg plays a pivotal role in transforming clinical insights into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cincinnati, Ohio, United States
Patients applied
Trial Officials
Marc E. Rothenberg, M.D., Ph.D.
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials